CALL NOW

Rated 5/5 on Google

Attorneys

Dr. Martha Rumore, Esq.

Dr. Martha M. Rumore is a pharmacist/attorney admitted to the NY, NJ, DC bars and is a registered patent attorney. She has a Pharm.D. from St. John’s University, a M.S. in Medical Communications and Drug Information from Long Island University, a J.D. from CUNY School of Law, and an LLM in Intellectual Property from the Benjamin N. Cardozo School of Law. Her practice focuses on FDA and healthcare regulatory services and intellectual property.

Read More >>
Anthony Mahajan

Anthony Mahajan, a seasoned leader with over two decades of crisis-management experience, specializes in federal and state government disputes. As a former, highly decorated federal prosecutor and top executive for major healthcare companies, he is recognized for his insightful approach in achieving successful resolutions within the complex healthcare system.

Read More >>
Diana Yastrovskaya

Diana Yastrovskaya is a distinguished legal professional specializing in healthcare-related proceedings, for which she has been recognized as a "Rising Star." Fluent in Russian, she defends companies and individuals nationwide against government entities, with expertise in regulatory matters. Diana earned her Juris Doctor, magna cum laude, from the Benjamin N. Cardozo School of Law.

Read More >>

As Seen On:

bloomberg logo

Recent Wins

Win over Optum

  • PBM audit uncovered 25,000 unit discrepancy of Zegerid and other violations.
  • PBM referred "fraud" to Massachusetts Attorney General—Medicaid Fraud Control Unit (MFCU).
  • MFCU indicted Pharmacy & Owner on numerous criminal charges, including False Claims & Larceny.
  • After HLA was retained, State dropped all charges before trial and abandoned the prosecution.
  • Owner admitted no wrongdoing and was not excluded; Pharmacy avoided all network sanctions.

Win over CVS

  • PBM audit uncovered $6.5 million inventory shortfall in compound cream APIs.
  • PBM referred "fraud" to U.S. Attorney's Office for the Eastern District of Pennsylvania, FBI, and HHS-OIG.
  • After HLA was retained, federal prosecutors declined to bring criminal charges against Owner.
  • Client settled case for $2.5 million, or less than 40% of the government's claimed loss on claims paid.
  • Owner admitted no wrongdoing, was not excluded, and suffered no licensing or other consequences.

Win over ESI

  • PBM audit uncovered $600,000 inventory shortfall in brand and generic medications.
  • PBM referred "fraud" to Pennsylvania Attorney General—Medicaid Fraud Control Unit (MFCU).
  • MFCU opened grand jury investigation against Pharmacy and Owner for Medicaid Fraud and Theft.
  • After HLA was retained, State declined to bring criminal charges against Owner.
  • MFCU charged the Pharmacy, a corporate entity, instead.

MORE ARTICLES BY CATEGORY

Get a Free Case REVIEW

100% Confidential & Secure. Your details are safe with us.

We'll speak soon!

In the meantime, why not find out more about us or visit our blog.

Alternatively, give us a call at (800) 345 - 4125

Oops! Something went wrong while submitting the form.